Niagen Bioscience (NAGE) Cash & Equivalents Growth (3y) (2017 - 2026)
Niagen Bioscience (NAGE) Cash & Equivalents Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 13.29% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 10.63% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -16.07% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.88% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 47.78% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Niagen Bioscience | 258.53 Mn | 191.98 Mn | 19.98 Mn | 42.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.21% |
| Dec 31, 2025 | 46.89% |
| Sep 30, 2025 | 69.24% |
| Jun 30, 2025 | 52.44% |
| Mar 31, 2025 | 38.37% |
| Dec 31, 2024 | 16.54% |
| Sep 30, 2024 | -0.71% |
| Jun 30, 2024 | -10.41% |
| Mar 31, 2024 | -14.88% |
| Dec 31, 2023 | 17.84% |
| Jun 30, 2023 | 11.81% |
| Mar 31, 2023 | 19.36% |
| Dec 31, 2022 | 2.81% |
| Sep 30, 2022 | -11.11% |
| Jun 30, 2022 | -4.76% |
| Mar 31, 2022 | 2.79% |
| Dec 31, 2021 | 7.66% |
| Sep 30, 2021 | 5.47% |
| Jun 30, 2021 | 5.11% |
| Mar 31, 2021 | 2.89% |